Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 8, 2001, Pages 957-962

  Schmandra, Thomas C ^a   Folz, Ina C ^a   Kimpel, Michael ^a   Fleming, Ingrid ^b   Holzer, Katharina ^a   Hanisch, Ernst W ^a  

^a Department of General and Vascular Surgery ^*  (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Aminoguanidine; Aortic rings; Cirrhosis; N nitro L arginine; Nitric oxide synthase; Vascular hyporeactivity

Indexed keywords

AMINOGUANIDINE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BILE DUCT LIGATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HEMODYNAMICS; IN VITRO STUDY; LIVER CIRRHOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUANIDINES; LIVER CIRRHOSIS, EXPERIMENTAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROARGININE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0034890902     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200108000-00014     Document Type: Article

References (37)

1. Bernardi M, Trevisani F. Systemic and regional hemodynamics in preascitic cirrhosis. J Hepatol 1997; 27: 588-591.
2. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359-1363.
3. Moller S, Christensen E, Henriksen JH. Continuous blood pressure monitoring in cirrhosis: relations to splanchnic and systemic haemodynamics. J Hepatol 1997; 27: 284-294.
4. Benoit JN, Womack WA, Hernandez L, Granger DN. `Forward’ and ‘backward’ flow mechanisms of portal hypertension: relative contributions in the portal vein stenosed rat. Gastroenterology 1985; 88: 1650-1654.
5. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244: G52-G57.
6. Shapiro MD, Nicholls KM, Groves BM, Kluge R, Chung H-M, Bichet DG. et al. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int 1985; 28: 206-211.
7. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984; 87: 1120-1126.
8. Bomzon A, Blendis LM. Vascular reactivity in experimental portal hypertension. Am J Physiol 1987; 252: 158.158.
9. Kiel JW, Pitts V, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am J Physiol 1985; 248: 192-195.
10. Michielsen PP, Boeckxstaens GE, Sys SU, Herman AG, Pelckmans PA. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats. Eur J Pharmacol 1995; 273: 167-174.
11. Pizcueta MP, Casamitjana R, Bosch J, Rodés J. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Physiol 1990; 258: 191-195.
12. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992; 262: 996-1001.
13. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103: 235-239.
14. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-1754.
15. Weigert AL, Martin PY, Niederberger M, Higa EM, McMurtry IF, Gines P. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995; 22: 1856-1862.
16. Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V. et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15: 343-349.
17. Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992; 263: 149-154.
18. Niederberger M, Ginés P, Tsai P, Martin P-Y, Morris K, Weigert A. et al. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology 1995; 21: 1625-1631.
19. Liu H, Song D, Lee SS. Increased nitric oxide synthase expression in aorta of cirrhotic rats. Life Sci 1999; 64: 1753-1759.
20. ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 1990; 176: 219-223.
21. Pizcuenta P, Piqué JM, Fernández M, Bosch J, Rodes J, Whittle BJ. et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-1915.
22. Schini VB, Vanhoutte PM. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. J Pharmacol Exp Ther 1992; 261: 553-559.
23. ω-nitro-L-arginine methyl ester in the rat aorta. Clin Exp Pharmacol Physiol 1995; 22: 641-645.
24. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
25. Lowry OH, Rosenbrough MJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
26. Fleming I, Fisslthaler B, Busse R. Calcium signalling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circ Res 1995; 76: 522-529.
27. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. J Exp Path 1984; 65: 305-311.
28. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiological messenger. Ann Intern Med 1994; 120: 227-237.
29. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role of nitric oxide? Lancet 1991; 337: 776-778.
30. Jiménez W, Ros J, Morales-Ruiz M, Navasa M, Sole M, Colmenero J. et al. Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients. Hepatology 1999; 30: 670-676.
31. Losonczy G, Bloch JF, Samsell L, Schoenl M, Venuto R, Baylis C. Impact of surgery on nitric oxide in rats: evidence for activation of inducible nitric oxide synthase. Kidney Int 1997; 51: 1943-1949.
32. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM. et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS-2) gene by cytokines: initial analysis of the human NOS-2. Proc Natl Acad Sci USA 1996; 93: 1054-1059.
33. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H. et al. Neopterin and soluble tumor necrosis factor type I in alcohol-induced cirrhosis. Hepatology 1995; 21: 976-978.
34. Martin P-Y, Xu DL, Niederberger M, Weigert A, Tsai P, St John J. et al. Upregulation of the endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 1996; 270: 494-499.
35. Morales-Ruiz M, Jiménez W, Pérez-Sala D, Ros J, Leivas A, Lamas S. et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996; 24: 1481-1486.
36. Ros J, Jiménez W, Lamas S, Claria J, Arroyo V, Rivera F, Rodes J. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 1995; 21: 554-560.
37. Lu JL, Schmiege LM, Kuo L, Liao JC. Downregulation of the endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Comm 1996; 225: 1-5.